๐Ÿฉบ ANTITHROMBOTIC AGENTS ๐Ÿท๏ธ Antithrombotic: Low molecular weight heparin (LMWH)
๐Ÿ“ฆ Formulations, Pack Sizes & Retail Prices Currency: Rs.
Dosage Form Reg. No Pack Size Trade Price (TP) Maximum Retail Price (MRP)
Inj 40 mg/0.4 ml โ€” 2 PFS Rs.1439.00 Rs.1694.00
Inj 60 mg/0.6 ml โ€” 2 PFS Rs.2259.00 Rs.2658.00
Inj 80 mg/0.8 ml โ€” 2 PFS Rs.2847.00 Rs.3115.00

๐Ÿ“‹ Indications & Clinical Dosage

*Prophylaxis Of Venous Thromboembolism Associated with General surgery, low risk:* BY DEEP SC INJ: Adult: 20 mg by deep SC injection 2 hrs pre-op, than 20 mg once daily for 7-10 days or until risk. *Orthopedic surgery, high risk:* BY DEEP SC INJ: Adult: 40 mg by deep SC injection 12 hrs pre-op, then 40 mg once daily for 7- I0 days or until risk. *Prophylaxis in acute illness and for bed-ridden patients:* BY DEEP SC INJ: Adult: 40mg by deep SC injection 12 hrspre-op, then 40 mg once daily forminimum 6 days and continue untilfull ambulation; max 14 days. *Treatment of deep venous thrombosis, pulmonary embolism:* BY DEEP SC INJ: Adult: 1.5 mg/kg by SC inj daily for minimum 5 days or until adequate oral anticoagulants is established. *Treatment of unstable Angina and non-Q wave MI:* 1 mg/kg by SC inj every 12 hr for minimum 2 days or until clinical stabilization, usually 2-8 days alongwith oral aspirin, 100-325 mg once daily. *Prevention of thrombus formation in the extracorporeal circulation during haemodialysis:* BY DEEP SC INJ: Adult: 1 mg/kg into arterial line of circuit prior to session. A further dose of 0.5-1 mg/kg may be given if session exceeds 4 hr. If high risk of haemorrhage, 0.5mg/kg for double vascular access or 0.75 mg/kg for single vascular access Children: Not recommended.

๐Ÿ’Š Mode of Administration

By deep SC injection to the left or right anterolateral and left or right posterolateral abdominal wall, alternate injection site between left and right. To avoid loss of drug from the 30 mg and 40 mg syringes, do not expel the air bubble from the syringe prior to injection. In order to minimize bruising, do not rub injection site. When administered in conjunction with a thrombolytic, enoxaparin should be given between 15 min before and 30 min after thestart of thrombolytic therapy.

โ›” Contraindications

Acute bacterial endocarditis, major bleeding disorders, increased risk of haemorrhage. thrombocylopenia, active peptic ulcer, haemorrhagic CVA

โš ๏ธ Precautions & Warnings

Hepatic insufficiency, hypertension, history of GI ulceration. Spinal or epidural anaesthesia, spinal puncture

๐Ÿ”„ Drug Interactions

Oral anticoagulants, heparin treatment, locoregional anaesthesia, antiplatelet agents, NSAIDs, aspirin. Dextran.

๐Ÿคฐ Pregnancy & Lactation Safety

Pregnancy Risk:
Caution advised
Lactation / Breastfeeding:
Caution advised

๐Ÿงช Compatibility & Storage Stability

Compatibility: Stable in NS.

Stability & Storage: Store at 15.C-25C (59F-77F). Do not freeze. Do not mix with other injections or infusions.

๐Ÿ”„ Alternative Brands

Other brands containing ENOXAPARIN

CLEXANE
SANOFI-AVENTIS
Rs.410.00 Inj 40 mg(017004)
Rs.361.50
ENOX
HIMMEL
Rs.1017.00
HEPANOX
MACTER
Rs.1,350.00
NOXANE
FEROZSONS
Rs.950.00
Rs.1,694.88

โšก Quick Actions